相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy
Ines Pires da Silva et al.
CANCER (2020)
Clinical predictors of survival in metastatic uveal melanoma
Daniel Lorenzo et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2019)
Response to Anti-PD-1 in Uveal Melanoma Without High-Volume Liver Metastasis
Douglas B. Johnson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma
Sara Silvia Violanti et al.
CANCERS (2019)
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
L. Khoja et al.
ANNALS OF ONCOLOGY (2019)
Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab
Suzanne L. Topalian et al.
JAMA ONCOLOGY (2019)
Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
Florian Castet et al.
CANCERS (2019)
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
Ernesto Rossi et al.
CANCERS (2019)
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Markus Heppt et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis
Elina S. Rantala et al.
MELANOMA RESEARCH (2019)
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
Richard D. Carvajal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Andre Kahles et al.
CANCER CELL (2018)
Treatment of uveal melanoma: where are we now?
Jessica Yang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
The safety and early efficacy of high-dose ipilimumab (IPI) and the combination nivolumab plus ipilimumab (NIVO plus IPI) in patients (pts) with uveal melanoma (UM).
Sapna Pradyuman Patel et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells
Teresa Mortera-Blanco et al.
BLOOD (2017)
Phase II multicenter, single arm, open label study of nivolumab (NIVO) in combination with ipilimumab (IPI) as first line in adult patients (pts) with metastatic uveal melanoma (MUM): GEM1402 NCT02626962.
Josep M. Piulats et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Identification of an Immunogenic Subset of Metastatic Uveal Melanoma
Luke D. Rothermel et al.
CLINICAL CANCER RESEARCH (2016)
Clinical Outcomes in Metastatic Uveal Melanoma Treated With PD-1 and PD-L1 Antibodies
Alain P. Algazi et al.
CANCER (2016)
Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab
F. Stephen Hodi et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Uveal melanoma as a target for immune-therapy
Marc Oliva et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naive Patients with Metastatic Uveal Melanoma
Lisa Zimmer et al.
PLOS ONE (2015)
GNA11 and N-RAS mutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system
M. Gessi et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Relative survival of patients with uveal melanoma managed in a single center
Josep Maria Caminal et al.
MELANOMA RESEARCH (2012)
Uveal Melanoma: Trends in Incidence, Treatment, and Survival
Arun D. Singh et al.
OPHTHALMOLOGY (2011)
Surgical management of liver metastases from uveal melanoma: 1.6 years' experience at the Institut Curie
P. Mariani et al.
EJSO (2009)
Targeted therapy for uveal melanoma
Pierre L. Triozzi et al.
CANCER TREATMENT REVIEWS (2008)
A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma
Penny A. O'Neill et al.
MELANOMA RESEARCH (2006)